Authors



Brian Pall, OD, MS, FAAO

Latest:

Transcript: First drug-eluting contact lens approved in Japan

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.


Eric Botts, OD

Latest:

Where to begin with dry eye technology

Adding laboratory testing and meibography helps patients and practices


Arthur Jung, OD

Latest:

5 reasons optometrists have failed to embrace myopia management

Some optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.


Barbara M. Wirostko, MD, FARVO

Latest:

Fact or fiction? A closer look at management options

At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.


Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO

Latest:

What's on the clinical wishlist for dry eye with Dr Bridgitte Shen Lee

Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders about what she would like to see develop as both a researcher and a clinician in the dry eye space.


Hanne Hansen, OD

Latest:

Angle closure presentation differs

Cases illustrate how acute and chronic angle-closure glaucoma are treated


Erin Tomiyama, OD, PhD, FAAO

Latest:

What you missed in glaucoma, dry eye, myopia, and more at CCS 2025

Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.


Joseph Sugg, OD

Latest:

A roundup of legislative news from 2025 so far

What to know about legislative moves that have been made through May this year.


Steven Leibowitz, MD

Latest:

Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.


Austin Lifferth, OD, FAAO

Latest:

All things glaucoma: A triad approach to evaluating the optic nerve, plus GlaucoMantras to carry with you

Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.


Heavin Maier, OD

Latest:

Contoured prism lenses enhance vision clarity and patient comfort

New technology improves precision of binocular vision disorder diagnosis and correction


Tracy Offerdahl, PHARMD, RPH, FAAO

Latest:

Biologic medications: The basics that every OD should know

This drug category is rapidly growing in the ophthalmic space, with more options in the pipeline


Sheri Rowen, MD, FACS, PCEO, FCWS

Latest:

Pearls for integrating dry eye disease management into your practice

Collaboration between ophthalmologists, optometrists can boost early detection.


Lotfi Merabet, OD, PhD, MPH

Latest:

Cerebral visual impairment

Documenting the visual effects and simplifying visual life.


Jeffrey Anshel, OD, FAAO

Latest:

Picking the right nutraceuticals for eye health supplementation

Jeffrey Anshel, OD, FAAO, outlines integrating nutritional supplements into patient eye care.



Lenna Walker OD, MS, FAAO

Latest:

Case report: OCT in the detection and diagnosis of neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.


Andrew S. Bruce, LDO, ABOM, NCLEM, FCLSA

Latest:

VEW 2024: Contact Lens Institute survey reveals factors that keep patients in contact lenses

The Contact Lens Institute unveiled a preview of their data on contact lens patient retention at Vision Expo West. The full report will be released later this year.


Chris Maraboli

Latest:

Open Your Eyes documentary released on multiple platforms

Open Your Eyes documentary now available on Apple TV+ and Google Play!


Jay M. Haynie, OD, FAAO, FORS

Latest:

Victoria Conference 2023: Staying current with the AMD landscape

Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.


Noor Chahal, BS

Latest:

Study finds significant variance across imaging modalities on sizes of geographic atrophy areas

A single, consistent modality leads to better geographic atrophy tracking.


Neda Gioia, OD, CNS, FOWNS

Latest:

AAOpt 2024: What optometrists think of the NutriTears supplement so far

Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.


Rhett Schiffman, MD, MHSA

Latest:

Transcript: Visus presbyopia drop gets FDA IND OK

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application


Heidi Sutter, OD, MPH

Latest:

Lessons learned from COVID-19: How to prepare for the next public health emergency

How eye care practices and doctors can prepare for the next pandemic


Sandeep Jain

Latest:

Telehealth success hinges on better tools

As the need for telemedicine increases, so does the urgency for creating new, less intrusive technology platforms.


Chris Kenrick, OD

Latest:

AAOpt 2022: The importance of perioperative management in corneal crosslinking

Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.


Jamie Ho, OD, FAAO, FCOVD

Latest:

SCOPA 2022: Low vision considerations, treatments, and tools

Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."


Essence Johnson, OD, FAAO

Latest:

NOA 2023: Dissecting the state of optometry

Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.


Gheorghe Necula, MD

Latest:

Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopia

An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.

© 2025 MJH Life Sciences

All rights reserved.